...
首页> 外文期刊>Biotechnology and Applied Biochemistry >Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression
【24h】

Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression

机译:SILAC(细胞培养物中氨基酸的稳定同位素标记)技术在组织蛋白质组表达定量比较中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Stable isotope labelling has recently become a popular tool for the quantitative profiling of the proteome, especially the emergence and development of the SILAC (stable isotope labelling with amino acids in cell culture) technique. Here we have expanded the application of SILAC to comparison of the relative protein expression levels between two different states of tissues based on cultured cells with [H-2]leucine labelling as an internal standard in mass spectra. The SILAC ratio of tissue proteins versus labelled cells was determined by the calculation of peak intensity of the pair of labelled and unlabelled peptide fragment ions from the mass spectra, and the relative expression level of proteins in two groups of tissues was estimated by calculating the ratio of their SILAC ratio. To validate our [H-2]leucine-based differential proteome analysis for tissues, we successfully compared two known proteins, one up-regulated vimentin and one down-regulated enoyl-CoA hydratase in human renal cancerous tissues versus human normal kidney tissues, which was previously confirmed by other groups using conventional two-dimensional PAGE analysis. Furthermore, we identified a previously unknown down-regulated protein, COX4I1 (cytochrome c oxidase subunit 4 isoform 1), in renal carcinoma tissues by this [H-2]leucine-based quantitative proteomics method, which was also validated by immunohistochemistry and Western-blot analysis. In conclusion, the application of the [H-2]leucine-based quantitative technique can be effectively expanded to comparison of the expression levels for the tissue proteome at different states, which would help us to identify new candidate biomarkers for tumours.
机译:稳定同位素标记近来已成为蛋白质组定量分析的流行工具,尤其是SILAC(在细胞培养中用氨基酸进行稳定同位素标记)技术的出现和发展。在这里,我们已经扩展了SILAC的应用,以基于[H-2]亮氨酸标记作为质谱内标的培养细胞,比较两种不同状态组织之间的相对蛋白质表达水平。通过从质谱计算一对标记和未标记的肽片段离子的峰强度来确定组织蛋白与标记细胞的SILAC比,并通过计算该比值来估算两组组织中蛋白质的相对表达水平他们的SILAC比率。为了验证我们基于[H-2]亮氨酸的组织差异蛋白质组分析,我们成功地比较了人肾癌组织和人正常肾组织中的两种已知蛋白,一种上调波形蛋白和一种下调烯酰辅酶A水化酶。先前已由其他小组使用常规二维PAGE分析确认。此外,我们通过这种基于[H-2]亮氨酸的定量蛋白质组学方法在肾癌组织中鉴定了一个未知的下调蛋白COX4I1(细胞色素C氧化酶亚基4亚型1),该蛋白也已通过免疫组化和Western-Western验证印迹分析。总之,基于[H-2]亮氨酸的定量技术的应用可以有效地扩展到比较不同状态下组织蛋白质组表达水平的水平,这将有助于我们识别新的肿瘤候选生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号